Inhibition of HIV replication by neuroleptic agents and their potential use in HIV infected patients with AIDS related dementia

International Journal of Antimicrobial Agents

Volumn 14, Issue 3, 2000, Pages 209-213

  Kristiansen, Jette E ^a   Hansen, John Bondo ^b  

^a Sonderborg Hospital   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

AIDS; Dementia; Neuroleptic agents

Indexed keywords

4 PHENYLPIPERIDINE DERIVATIVE; AMITRIPTYLINE; CHLORPROTHIXENE; CITALOPRAM; FEMOXETINE; FLUPENTIXOL; NEUROLEPTIC AGENT; NORTRIPTYLINE; PAROXETINE; ZUCLOPENTHIXOL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ARTICLE; DEMENTIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOMER; PRIORITY JOURNAL; VIRUS REPLICATION;

ANTIBODIES, MONOCLONAL; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CELL LINE; FLUPENTHIXOL; GENE PRODUCTS, GAG; HIV ANTIGENS; HIV CORE PROTEIN P24; HIV-1; HUMANS; IMMUNOHISTOCHEMISTRY; PAROXETINE; PIPERIDINES; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0034083364     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(99)00157-0     Document Type: Article

References (47)

1. Ehrlich P. Uber die Methylenblaureaction der lebenden Nervensubstanz. Himmelweit F., Marquardt M., Dale H. The Collected Papers of Paul Ehrlich. 1:1956;500-508 Pergamon Press, London. (reprinted from Dtsch. Med. Wochenschr. 1886).
2. Ehrlich P. Chemotherapeutics: scientific principles, methods and results. Lancet. ii:1913;445-451.
3. . Charpentier P., Gailliot P., Jacob R., Gaudechon J., Buisson P. Rescherches sur les di methylaminopropyl-N-phenothiazines substituees. C.R. Acad. Sci. 235:1952;59-60.
4. Decourt P., Gastal R., Grenat R. Etude de lactim narcobiotique sur legs germs microbiens. C.R. Acad. Sci. 2:1953;1109-1111.
5. Decourt P. Activite narcobiotique e derives de la phenothiazine et son importance therapeutice. C.R. Acad. Sci. 236:1953;1195-1197.
6. Bourdon J.L. Contribution a letude des proprietes antibiotiques de la chlorpromazine ou 4560 RP. Ann. Inst. Pasteur. 101:1961;876-886.
7. Loddo B., Zanda G.E. Influenza di derivati della fenotiazina sulla moltiplicazione. In vitro di cellule vegetali di microorganismi, di virus. Arch. Int. Pharmacodyn. CXXXIII(1-2):1961;1-9.
8. Molnar J, Mandi Y, Kiraly J. Antibacterial effect of some phenothiazine compounds and R-factor elimination by chlorpromazine. Acta Microbiol Acad Sci Hung 1976;23:45-54.
9. Dastidar SG, Saha PK, Sanyamat B, Chakrabarty AN. Antibacterial activity of ambrodryl and benadryl. J Appl Biotechnol 1976;41:209-214.
10. Kristiansen J.E.H. Experiments to illustrate the effect of chlorpromazine on the permeability of the bacterial cell wall. Acta Path. Microbiol. Scand. Sect. B. 87:1979;317-319.
11. Kristiansen J.E.H., Mortensen I. Stereo-isomeric dissociation of the antibacterial and the neuroleptic effect of clopenthixol. Acta Path. Microbiol. Scand. B. 89:1981;437-438.
12. Kristiansen J.E., Sebbesen O., Frimodt-Moller N., Aaes-Jørgensen T., Hvidberg E.F. Synergy between a non-neuroleptic thioxanthene stereo-isomeric and penicillin in vivo. APMIS Acta Path. Microbiol. Immunol. Scand. 96:1988;1079-1084.
13. Kristiansen J.E. Dyes, antipsychotic drugs and antimicrobial activity. Fragments of a development, with special reference to the influence of Paul Ehrlich. Dan Medical Bull. 36:1989;178-185.
14. Kristiansen JE. The antimicrobial activity of psychotherapeutic drugs and stereo-isomeric analogues. Lægeforeningens Forlag. Thesis, DSCM University of Copenhagen, Denmark, 1990.
15. Guttmann P., Ehrlich P. Uber die wirkung des Methylenblau bei Malaria. Berliner Klin. Wochenschr. 39:1891;953-956.
16. Forrest I.S., Quesada F., Deitchman G.L. Unicellular organisms as model systems for the mode of action of phenothiazine and related drugs. Proc. West. Pharmacol. Soc. 7:1964;42-44.
17. Kristiansen J.E., Jepsen S. Brief report: the susceptibility of Plasmodium falciparum in vitro to chlorpromazine and the stereo-isomeric compounds cis (Z)- and trans (E)-clopenthixol. Acta Path. Microbiol. Immunol. Scand. B. 93:1985;249-251.
18. Bitonti A.J., Sjoerdima A., McCann P.P., Kyle D.E., Odriola A.M.J., Rossan R.N., Milhouse W.K., Davidson Jr D.E. Reversal of chloroquine resistance in malaria parasite Plasmodium by desipramine. Science. 242:1988;1301-1303.
19. Peters W., Ekong R., Robinson B.L., Warhust D.C., Zing-Ging P. Antihistaminic drug that reverse chloroquin resistance in Plasmodium falciparum. Lancet. 1989:1989;334-335.
20. Henriksen T.H., Lende S. Treatment of diffuse cutaneous Leishmaniasis with chlorpromazine ointment. Lancet. I:1983;126.
21. Pearson R.D., Hall D., Harcus J.L., Manian A.A., Hewlett E.L. Characterization of the lethal effect of chlorpromazine and its derivatives on the protozoan Leishmania donovani. Clin. Res. 29:1981;837A.
22. Pearson R.D., Manian A.A., Harcus J.L., Hall D., Hewlett E.L. Lethal effect of phenothiazine neuroleptics on the pathogenic protozoan Leishmania donovani. Science. 217:1982;369-371.
23. Pearson R.D., Manian A.A., Hall D., Harcus J.L, Hewlett E.L. Antileishmanial activity of chlorpromazine. Antimicrob. Agents Chemother. 25:1984;571-574.
24. Lind K, Kristiansen JEH. Antibiotic effect of chlorpromazine on mycoplasmas, Proceedings of the 4th International Organization of Mycoplasmalogy (IOM) Congress. Tokyo, September 1982.
25. Schuster F.L., Mandel N. Phenothiazine compounds inhibit in vitro growth of pathogenic free-living amoebae. Antimicrob. Agents Chemother. 25(1):1984;109-112.
26. Romano C., Galdiero F. Azione della cloropromazina sul dimorfismo della Candida albicans. Nuovi Ann. D'Igiene Microbiol. 26:1975;461-464.
27. Wood N.C., Nugent K.M. Inhibitory effects of chlorpromazine on Candida species. Antimicrob. Agents Chemother. 27:1985;692-694.
28. Eilam Y., Polacheck I., Ben-Gigi G., Chernichovsky D. Activity of phenothiazines against medically important yeasts. Antimicrob. Agents Chemother. 31:1987;834-836.
29. Patou G., Crow T.J., Taylor G.R. The effects of psychotropic drugs on synthesis of DNA and the infectivity of Herpes simplex virus. Biol. Psychiatry. 21:1986;1221-1225.
30. Kristiansen J.E., Andersen L.P., Vestergaard B.F., Hvidberg E.F. Effect of selected neuroleptic agents and stereo-isomeric analogues on virus and eukaryotic cells. Pharmacol. Toxicol. 68:1991;399-403.
31. Mortensen I, Kristiansen J.E., Christensen A.V., Hvidberg E.F. The antibacterial effect of some neuroleptics on strains isolated from patients with meningitis. Pharmacol. Toxicol. 71:1992;449-451.
32. Kristiansen J.E., Amaral L. The potential management of resistant infections with non-antibiotics. J. Antimicrob. Chemother. 40:1997;319-327.
33. Krizanova O., Ciampor F., Veber P. Influence of chlorpromazine on the replication of influenza virus in chicken embryo cells. Acta Virol. 26:1982;209-216.
34. Bohn W., Rutter G., Hohenberg H., Mannweiler K. Inhibition of measles virus budding by phenothiazines. Virology. 130:1983;44-46.
35. Alcarcon B., Gonzáles M.E., Carrasco L. Antiherpes virus action of atropin. Antimicrob. Agents Chemother. 26:1984;702-706.
36. Kristiansen J.E. Antimicrobial activity of non-antibiotics. ASM News. 57:1991;135-139.
37. Kristiansen J.E.H. Chlorpromazine: non-antibiotics with antimicrobial activity - new insights in managing resistance? Curr. Opin. Investigat. Drugs. 2:1993;587-591.
38. Sarin P.S., Agrawal S., Cireitra M.P., Goodchild I., Ikeuchi T, Zamecnik P.C. Inhibition of aquired immunodeficiency syndrome virus by oligodeoxynucleoside methyphosphonates. Proc. Nat. Acad. Sci. USA. 85:1988;7448-7451.
39. Lassen Buus J., Squires R.F., Christensen J.A., Molander L. Neurochemical and pharmacological studies on a new 5HT-uptake-inhibitor, FG 4963, with potential antidepressant properties. Psychopharmacologia. 42:1975;21-26.
40. Engelstoft M, Hansen JB. Synthesis and 5HT modulating activity of stereoisomers of 3-phenoxymethyl-4-phenylpiperidenes. Acta Chem Scand 1996;50:164-169.
41. Petersen P.V., Nielsen I.M., Pedersen V., Jorgensen A., Lassen N. Thioxanthenes. Usdin E., Forrest I. Psychotherapeutic drugs. 1977;827-867 Marcel Dekker, New York.
42. Kristiansen J.E., Gaarslev K. The antibacterial effect of selected neurotropics on Vibrio cholerae. Acta Path. Microbiol. Immunol. Scand. B. 93:1985;249-251.
43. Rechnitzer C., Kristiansen J.E., Kharazmi A. In vitro modulation of human neutrophil chemotaxis by cis (Z)- and trans (E)-clopenthixol and chlorpromazine. Acta Path. Microbiol. Immunol. Scand. Sect. C. 93:1985;199-203.
44. Kristiansen J.E., Vergmann B. The antibacterial effect of selected phenothiazines and thioxanthenes on slow-growing mycobacteria. Acta Path. Microbiol. Immunol. Scand. Sect. B. 94:1986;393-398.
45. Crowle A.J., Douvas G.S., May M.H. Chlorpromazine: a drug potentially useful for treating mycobacterial infections. Exp. Chemother. 38:1992;410-419.
46. Amaral L., Kristiansen J.E., Abebe L., Millett W. Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis. J. Antimicrob. Chemother. 38:1997;1049-1053.
47. Skinner G.R.B., Hartley C., Buchan A., Harper L., Gallimore P. The effect of lithium chloride on the replication of Herpes simplex virus. Med. Microbiol. Immunol. 168:1980;139-148.